Cellebrite DI Ltd. (CLBT)

Cellebrite shows strong cash generation, high margins, and a net-cash balance sheet, supported by solid multi-year revenue growth. Recent SEC updates point to longer sales cycles, a reset of 2026 ARR/revenue expectations, and a CEO transition, which adds near-term uncertainty. Valuation is still rich (P/E and EV/EBITDA elevated) and intrinsic-value outputs are not consistently supportive, so the setup looks more like a watchlist name than a straightforward value entry right now.

Dominant near-term item is the U.S. redomicile ongoing process (announced 2026-09-14, TBD, neutral market reception); sentiment delta is determinate but flat (~+0.08 → ~+0.08). One moderate red flag fires — abrupt CEO exit (~Aug 20) with no named successor surfaced (≤60d) — applying the moderate cap, and with no rewarded bullish element in-window plus the Q2 miss/guidance-cut overhang still digesting, the setup is weak/forming.

CLBT is base-building after the early-August crash (capitulation low $9.58 on 08-13): price has reclaimed the SMA20 ($11.58) and EMA9 ($11.55), the MACD histogram is positive and expanding (0.08 → 0.12), RSI has recovered from 37.66 to 46.94, and Williams %R is off the oversold extreme (-85.5 → -44.2). But the tape remains below the EMA21 ($11.87), SMA50 ($13.38) and SMA200 ($14.46), the MACD line is still negative (-0.46), and ADX 27.94 mostly measures the prior decline rather than a new upmove — an early repair bounce, mixed, chart score 3. The trade plan is blocked outright by the qualitative override gate: qualitativeScore 2 (upstream moderate red flag — abrupt CEO exit ~2026-08-20/21 with no successor surfaced) is below the required floor of 3, and the shadow sum-gate branch is disabled (flag false). All other Step-00 gates passed: price $11.82 ≤ $25, fundamentalScore 3 ≥ 3, symbol resolved, max overnight gap 2.23% ≤ 5%, recent 3-session dollar volume ~$27.3M ≥ $1.5M, all 18 indicators loaded, no dividend or confirmed-earnings event inside the 15-trading-day holding window (horizon 2026-10-08; next confirmed earnings 2026-11-11), ATR14 4.8% of price ≥ 1.0% floor, and the feed is current (dataAsOf 2026-09-17).